Alzheimer's disease pathophysiology: Difference between revisions

	Alzheimer's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alzheimer's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Alzheimer's disease pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Alzheimer's disease pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Alzheimer's disease pathophysiology
CDC on Alzheimer's disease pathophysiology
Alzheimer's disease pathophysiology in the news
Blogs on Alzheimer's disease pathophysiology
Directions to Hospitals Treating Alzheimer's disease
Risk calculators and risk factors for Alzheimer's disease pathophysiology

Revision as of 16:48, 17 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 12: / Line 12: @@
 ==Pathogenesis==
-[[Image:Alzheimer's disease - MRI.jpg|left|150x200px|frame|[[MRI]] images of a normal aged brain (right) and an Alzheimer's patient's brain (left). In the Alzheimer brain, atrophy is clearly seen.]]
-<gallery>
-Image:TAU HIGH.JPG|Microscopy image of a neurofibrillary tangle, conformed by hyperphosphorylated tau protein.
-Image:TANGLES HIGH.jpg|In Alzheimer's disease, changes in tau protein lead to the disintegration of microtubules in brain cells.
-</gallery>
 ===Associated Conditions===